Indian drugmaker Ranbaxy still has exclusive rights for Nexium generic -CEO
October 28, 2014 at 11:35 AM EDT
MUMBAI, Oct 28 (Reuters) - Indian drugmaker Ranbaxy Laboratories still has exclusive rights to the launch of AstraZeneca's heartburn drug Nexium in the United States, it said on Tuesday, despite regulatory concern over the manufacturing process.
